These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15950729)

  • 1. Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily.
    Li L; Bouvier M
    Mol Immunol; 2005 Jul; 42(11):1331-44. PubMed ID: 15950729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development.
    Threlkeld SC; Wentworth PA; Kalams SA; Wilkes BM; Ruhl DJ; Keogh E; Sidney J; Southwood S; Walker BD; Sette A
    J Immunol; 1997 Aug; 159(4):1648-57. PubMed ID: 9257824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
    Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH
    Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.
    Menssen R; Orth P; Ziegler A; Saenger W
    J Mol Biol; 1999 Jan; 285(2):645-53. PubMed ID: 9878435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.
    Hülsmeyer M; Welfle K; Pöhlmann T; Misselwitz R; Alexiev U; Welfle H; Saenger W; Uchanska-Ziegler B; Ziegler A
    J Mol Biol; 2005 Mar; 346(5):1367-79. PubMed ID: 15713487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype.
    Cowan EP; Jordan BR; Coligan JE
    J Immunol; 1985 Oct; 135(4):2835-41. PubMed ID: 2993417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules.
    Sidney J; Grey HM; Southwood S; Celis E; Wentworth PA; del Guercio MF; Kubo RT; Chesnut RW; Sette A
    Hum Immunol; 1996 Feb; 45(2):79-93. PubMed ID: 8882405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants.
    Sire J; Chimini G; Boretto J; Toubert A; Kahn-Perles B; Layet C; Sodoyer R; Lemonnier F; Jordan B
    J Immunol; 1988 Apr; 140(7):2422-30. PubMed ID: 2450922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes.
    Zhang S; Liu J; Cheng H; Tan S; Qi J; Yan J; Gao GF
    Mol Immunol; 2011 Oct; 49(1-2):395-401. PubMed ID: 21943705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes.
    Sudo T; Kamikawaji N; Kimura A; Date Y; Savoie CJ; Nakashima H; Furuichi E; Kuhara S; Sasazuki T
    J Immunol; 1995 Nov; 155(10):4749-56. PubMed ID: 7594476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
    J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B27: a registry of constitutive peptide ligands.
    Lopez de Castro JA; Alvarez I; Marcilla M; Paradela A; Ramos M; Sesma L; Vázquez M
    Tissue Antigens; 2004 May; 63(5):424-45. PubMed ID: 15104674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
    Griffin TA; Yuan J; Friede T; Stevanovic S; Ariyoshi K; Rowland-Jones SL; Rammensee HG; Colbert RA
    J Immunol; 1997 Nov; 159(10):4887-97. PubMed ID: 9366414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.
    Hansasuta P; Dong T; Thananchai H; Weekes M; Willberg C; Aldemir H; Rowland-Jones S; Braud VM
    Eur J Immunol; 2004 Jun; 34(6):1673-9. PubMed ID: 15162437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients.
    Wieckowski S; Baumgaertner P; Corthesy P; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Oct; 183(8):5397-406. PubMed ID: 19786555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.
    Burrows JM; Wynn KK; Tynan FE; Archbold J; Miles JJ; Bell MJ; Brennan RM; Walker S; McCluskey J; Rossjohn J; Khanna R; Burrows SR
    Eur J Immunol; 2007 Apr; 37(4):946-53. PubMed ID: 17357107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.
    Scapozza L; Rognan D; Folkers G; Daser A
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):541-9. PubMed ID: 15299842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.